The success of current systemic and intravesical therapeutic agents, such as cisplatin, thiotepa, Adriamycin, mitomycin C, and bacillus Calmette - Guerin, is limited with recurrence rates reduced to 17 - 44%.	"cisplatin	77	86	Chemical"	"thiotepa	88	96	Chemical"	"Adriamycin	98	108	Chemical"	"mitomycin C	110	121	Chemical"	"[{""token"": ""cisplatin"", ""start_span"": 77, ""end_span"": 86, ""type"": ""Chemical""}, {""token"": ""thiotepa"", ""start_span"": 88, ""end_span"": 96, ""type"": ""Chemical""}, {""token"": ""Adriamycin"", ""start_span"": 98, ""end_span"": 108, ""type"": ""Chemical""}, {""token"": ""mitomycin C"", ""start_span"": 110, ""end_span"": 121, ""type"": ""Chemical""}]"
Both cis - 9, trans - 11 and trans - 10, cis - 12 CLA isomers were effective in inhibiting angiogenesis in vitro in a dose - dependent fashion.	"cis - 9	5	12	Chemical"	"trans - 11	14	24	Chemical"	"trans - 10	29	39	Chemical"	"cis - 12 CLA isomers	41	61	Chemical"	"[{""token"": ""cis - 9"", ""start_span"": 5, ""end_span"": 12, ""type"": ""Chemical""}, {""token"": ""trans - 11"", ""start_span"": 14, ""end_span"": 24, ""type"": ""Chemical""}, {""token"": ""trans - 10"", ""start_span"": 29, ""end_span"": 39, ""type"": ""Chemical""}, {""token"": ""cis - 12 CLA isomers"", ""start_span"": 41, ""end_span"": 61, ""type"": ""Chemical""}]"
Mice primed with dimethyl - benz [ a] anthracene ( DMBA) were topically exposed to Cum - OOH ( 82. 6 micromol) or the positive control, 12 - O - tetradecanoylphorbol - 13 - acetate ( TPA, 17 nmol), twice weekly for 29 weeks.	"DMBA	51	55	Chemical"	"Cum - OOH	83	92	Chemical"	"12 - O - tetradecanoylphorbol - 13 - acetate	136	180	Chemical"	"TPA	183	186	Chemical"	"[{""token"": ""DMBA"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Chemical""}, {""token"": ""Cum - OOH"", ""start_span"": 83, ""end_span"": 92, ""type"": ""Chemical""}, {""token"": ""12 - O - tetradecanoylphorbol - 13 - acetate"", ""start_span"": 136, ""end_span"": 180, ""type"": ""Chemical""}, {""token"": ""TPA"", ""start_span"": 183, ""end_span"": 186, ""type"": ""Chemical""}]"
A greater accumulation of peroxidative products ( thiobarbituric acid - reactive substances), inflammation and decreased levels of GSH and total antioxidant reserves were also observed in the skin of DMBA - Cum - OOH - exposed mice.	"thiobarbituric acid	50	69	Chemical"	"GSH	131	134	Chemical"	"DMBA	200	204	Chemical"	"Cum - OOH	207	216	Chemical"	"[{""token"": ""thiobarbituric acid"", ""start_span"": 50, ""end_span"": 69, ""type"": ""Chemical""}, {""token"": ""GSH"", ""start_span"": 131, ""end_span"": 134, ""type"": ""Chemical""}, {""token"": ""DMBA"", ""start_span"": 200, ""end_span"": 204, ""type"": ""Chemical""}, {""token"": ""Cum - OOH"", ""start_span"": 207, ""end_span"": 216, ""type"": ""Chemical""}]"
TP catalyzes the conversion of thymidine to thymine and doxyribose - 1 - phosphate ( dR - 1 - P).	"thymidine	31	40	Chemical"	"thymine	44	51	Chemical"	"doxyribose - 1 - phosphate	56	82	Chemical"	"dR - 1 - P	85	95	Chemical"	"[{""token"": ""thymidine"", ""start_span"": 31, ""end_span"": 40, ""type"": ""Chemical""}, {""token"": ""thymine"", ""start_span"": 44, ""end_span"": 51, ""type"": ""Chemical""}, {""token"": ""doxyribose - 1 - phosphate"", ""start_span"": 56, ""end_span"": 82, ""type"": ""Chemical""}, {""token"": ""dR - 1 - P"", ""start_span"": 85, ""end_span"": 95, ""type"": ""Chemical""}]"
L - deoxyribose ( L - dR) and thymidine phosphorylase inhibitor ( TPI) can reverse these effects.	"L - deoxyribose	0	15	Chemical"	"L - dR	18	24	Chemical"	"thymidine phosphorylase inhibitor	30	63	Chemical"	"TPI	66	69	Chemical"	"[{""token"": ""L - deoxyribose"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Chemical""}, {""token"": ""L - dR"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Chemical""}, {""token"": ""thymidine phosphorylase inhibitor"", ""start_span"": 30, ""end_span"": 63, ""type"": ""Chemical""}, {""token"": ""TPI"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Chemical""}]"
Pretreatment with DMI followed by combination of DMI and FA decreased GR - mediated transcription more than pretreatment with FA.	"DMI	18	21	Chemical"	"DMI	49	52	Chemical"	"FA	57	59	Chemical"	"FA	126	128	Chemical"	"[{""token"": ""DMI"", ""start_span"": 18, ""end_span"": 21, ""type"": ""Chemical""}, {""token"": ""DMI"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Chemical""}, {""token"": ""FA"", ""start_span"": 57, ""end_span"": 59, ""type"": ""Chemical""}, {""token"": ""FA"", ""start_span"": 126, ""end_span"": 128, ""type"": ""Chemical""}]"
The expression of metallothionein - 1 ( Mt - 1) gene, which is regulated by GR, was induced significantly by the combination of DMI and FA, and enhanced significantly by pretreatment with FA but not DMI.	"DMI	128	131	Chemical"	"FA	136	138	Chemical"	"FA	188	190	Chemical"	"DMI	199	202	Chemical"	"[{""token"": ""DMI"", ""start_span"": 128, ""end_span"": 131, ""type"": ""Chemical""}, {""token"": ""FA"", ""start_span"": 136, ""end_span"": 138, ""type"": ""Chemical""}, {""token"": ""FA"", ""start_span"": 188, ""end_span"": 190, ""type"": ""Chemical""}, {""token"": ""DMI"", ""start_span"": 199, ""end_span"": 202, ""type"": ""Chemical""}]"
In vitro cell proliferation, combination studies and vascular endothelial growth factor ( VEGF) secretion analyses were performed on endothelial ( HMVEC - d) and colorectal cancer ( HT - 29) cells exposed for 144 h to metronomic concentrations of SN - 38, the active metabolite of CPT - 11, L - OHP and 5 - FU.	"SN - 38	247	254	Chemical"	"CPT - 11	281	289	Chemical"	"L - OHP	291	298	Chemical"	"5 - FU	303	309	Chemical"	"[{""token"": ""SN - 38"", ""start_span"": 247, ""end_span"": 254, ""type"": ""Chemical""}, {""token"": ""CPT - 11"", ""start_span"": 281, ""end_span"": 289, ""type"": ""Chemical""}, {""token"": ""L - OHP"", ""start_span"": 291, ""end_span"": 298, ""type"": ""Chemical""}, {""token"": ""5 - FU"", ""start_span"": 303, ""end_span"": 309, ""type"": ""Chemical""}]"
VTAs can be divided into two groups: antiangiogenic agents and vascular - disrupting agents ( VDAs).	"VTAs	0	4	Chemical"	"antiangiogenic agents	37	58	Chemical"	"vascular - disrupting agents	63	91	Chemical"	"VDAs	94	98	Chemical"	"[{""token"": ""VTAs"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Chemical""}, {""token"": ""antiangiogenic agents"", ""start_span"": 37, ""end_span"": 58, ""type"": ""Chemical""}, {""token"": ""vascular - disrupting agents"", ""start_span"": 63, ""end_span"": 91, ""type"": ""Chemical""}, {""token"": ""VDAs"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Chemical""}]"
From these data, as well as earlier evidence demonstrating that the reduced nicotinamide adenine dinucleotide ( NADH) shuttle in these cells requires a transaminase step and is thus identified as the malate - aspartate shuttle ( W. V. V. Greenhouse and A. L. Lehninger, Cancer Res., 36: 1392 - 1396, 1976), metabolic flux diagrams were constructed for the five cell lines.	"nicotinamide adenine dinucleotide	76	109	Chemical"	"NADH	112	116	Chemical"	"malate	200	206	Chemical"	"aspartate	209	218	Chemical"	"[{""token"": ""nicotinamide adenine dinucleotide"", ""start_span"": 76, ""end_span"": 109, ""type"": ""Chemical""}, {""token"": ""NADH"", ""start_span"": 112, ""end_span"": 116, ""type"": ""Chemical""}, {""token"": ""malate"", ""start_span"": 200, ""end_span"": 206, ""type"": ""Chemical""}, {""token"": ""aspartate"", ""start_span"": 209, ""end_span"": 218, ""type"": ""Chemical""}]"
These diagrams show the relative rates of glycolysis, the tricarboxylic acid cycle, electron transport, and the malate - aspartate shuttle in these tumors.	"tricarboxylic acid	58	76	Chemical"	"electron	84	92	Chemical"	"malate	112	118	Chemical"	"aspartate	121	130	Chemical"	"[{""token"": ""tricarboxylic acid"", ""start_span"": 58, ""end_span"": 76, ""type"": ""Chemical""}, {""token"": ""electron"", ""start_span"": 84, ""end_span"": 92, ""type"": ""Chemical""}, {""token"": ""malate"", ""start_span"": 112, ""end_span"": 118, ""type"": ""Chemical""}, {""token"": ""aspartate"", ""start_span"": 121, ""end_span"": 130, ""type"": ""Chemical""}]"
Using tamoxifen and doxorubicin - sensitive and - resistant breast cancer cell lines as models, we found that doxorubicin - but not tamoxifen - resistance is associated with nuclear accumulation of FOXO3a, consistent with the finding that sustained nuclear FOXO3a is associated with poor prognosis.	"tamoxifen	6	15	Chemical"	"doxorubicin	20	31	Chemical"	"doxorubicin	110	121	Chemical"	"tamoxifen	132	141	Chemical"	"[{""token"": ""tamoxifen"", ""start_span"": 6, ""end_span"": 15, ""type"": ""Chemical""}, {""token"": ""doxorubicin"", ""start_span"": 20, ""end_span"": 31, ""type"": ""Chemical""}, {""token"": ""doxorubicin"", ""start_span"": 110, ""end_span"": 121, ""type"": ""Chemical""}, {""token"": ""tamoxifen"", ""start_span"": 132, ""end_span"": 141, ""type"": ""Chemical""}]"
DNA microarray analysis of treated tumor xenografts revealed significantly decreased expression of genes regulating glucose and thymidine metabolism and revealed changes in apoptotic genes, suggesting that the imaging tracers FDG, 3 - deoxy - 3 - [ ( 18) F] fluorothymidine, and annexin V could serve as potential imaging biomarkers for RAF265 therapy monitoring.	"glucose	116	123	Chemical"	"thymidine	128	137	Chemical"	"FDG	226	229	Chemical"	"RAF265	337	343	Chemical"	"[{""token"": ""glucose"", ""start_span"": 116, ""end_span"": 123, ""type"": ""Chemical""}, {""token"": ""thymidine"", ""start_span"": 128, ""end_span"": 137, ""type"": ""Chemical""}, {""token"": ""FDG"", ""start_span"": 226, ""end_span"": 229, ""type"": ""Chemical""}, {""token"": ""RAF265"", ""start_span"": 337, ""end_span"": 343, ""type"": ""Chemical""}]"
Two approaches were used to measure protein kinase C: assay of intact cells for inhibition of epidermal growth factor ( EGF) binding in response to phorbol dibutyrate ( PDBu); and assay of detergent extracts for total calcium, phospholipid - dependent kinase activity.	"phorbol dibutyrate	148	166	Chemical"	"PDBu	169	173	Chemical"	"calcium	218	225	Chemical"	"phospholipid	227	239	Chemical"	"[{""token"": ""phorbol dibutyrate"", ""start_span"": 148, ""end_span"": 166, ""type"": ""Chemical""}, {""token"": ""PDBu"", ""start_span"": 169, ""end_span"": 173, ""type"": ""Chemical""}, {""token"": ""calcium"", ""start_span"": 218, ""end_span"": 225, ""type"": ""Chemical""}, {""token"": ""phospholipid"", ""start_span"": 227, ""end_span"": 239, ""type"": ""Chemical""}]"
The effects on hemostasis of DM - COOK, DTIC and ICRF - 159 have thus been examined in comparison with those of a purely cytotoxic agent, cyclophosphamide, in mice bearing i. m.	"DM - COOK	29	38	Chemical"	"DTIC	40	44	Chemical"	"ICRF - 159	49	59	Chemical"	"cyclophosphamide	138	154	Chemical"	"[{""token"": ""DM - COOK"", ""start_span"": 29, ""end_span"": 38, ""type"": ""Chemical""}, {""token"": ""DTIC"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Chemical""}, {""token"": ""ICRF - 159"", ""start_span"": 49, ""end_span"": 59, ""type"": ""Chemical""}, {""token"": ""cyclophosphamide"", ""start_span"": 138, ""end_span"": 154, ""type"": ""Chemical""}]"
When the macro - molecular synthesis inhibitor cycloheximide ( CHX) or actinomycin D ( Act D) was present for 26 hours in the absence of GM - CSF and FBS, apoptosis was inhibited.	"cycloheximide	47	60	Chemical"	"CHX	63	66	Chemical"	"actinomycin D	71	84	Chemical"	"Act D	87	92	Chemical"	"[{""token"": ""cycloheximide"", ""start_span"": 47, ""end_span"": 60, ""type"": ""Chemical""}, {""token"": ""CHX"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Chemical""}, {""token"": ""actinomycin D"", ""start_span"": 71, ""end_span"": 84, ""type"": ""Chemical""}, {""token"": ""Act D"", ""start_span"": 87, ""end_span"": 92, ""type"": ""Chemical""}]"
Glucose metabolism was studied using an ECAT EXACT 47 positron emission tomography ( PET) camera and fluorine - 18 fluorodeoxyglucose ( 18F - FDG); 123I - IMT uptake was measured with the triple - headed single - photon emission tomography ( SPET) camera, MULTISPECT 3.	"Glucose	0	7	Chemical"	"fluorine - 18 fluorodeoxyglucose	101	133	Chemical"	"18F - FDG	136	145	Chemical"	"123I - IMT	148	158	Chemical"	"[{""token"": ""Glucose"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical""}, {""token"": ""fluorine - 18 fluorodeoxyglucose"", ""start_span"": 101, ""end_span"": 133, ""type"": ""Chemical""}, {""token"": ""18F - FDG"", ""start_span"": 136, ""end_span"": 145, ""type"": ""Chemical""}, {""token"": ""123I - IMT"", ""start_span"": 148, ""end_span"": 158, ""type"": ""Chemical""}]"
Assuming discrimination thresholds between high - grade and low - grade tumours of 0. 8 for 18F - FDG uptake and 1. 8 for 123I - IMT uptake, the accuracy values of 18F - FDG PET and 123I - IMT SPET for differentiating between high - grade and low - grade tumours were 21 / 23 ( 91%) and 19 / 23 ( 83%), respectively.	"18F - FDG	92	101	Chemical"	"123I - IMT	122	132	Chemical"	"18F - FDG	164	173	Chemical"	"123I - IMT	182	192	Chemical"	"[{""token"": ""18F - FDG"", ""start_span"": 92, ""end_span"": 101, ""type"": ""Chemical""}, {""token"": ""123I - IMT"", ""start_span"": 122, ""end_span"": 132, ""type"": ""Chemical""}, {""token"": ""18F - FDG"", ""start_span"": 164, ""end_span"": 173, ""type"": ""Chemical""}, {""token"": ""123I - IMT"", ""start_span"": 182, ""end_span"": 192, ""type"": ""Chemical""}]"
13C and 1H nuclear magnetic resonance spectroscopy ( NMR) was used to investigate the metabolism of L - lactate and D - glucose in C6 glioma cells.	"13C	0	3	Chemical"	"1H	8	10	Chemical"	"L - lactate	100	111	Chemical"	"D - glucose	116	127	Chemical"	"[{""token"": ""13C"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Chemical""}, {""token"": ""1H"", ""start_span"": 8, ""end_span"": 10, ""type"": ""Chemical""}, {""token"": ""L - lactate"", ""start_span"": 100, ""end_span"": 111, ""type"": ""Chemical""}, {""token"": ""D - glucose"", ""start_span"": 116, ""end_span"": 127, ""type"": ""Chemical""}]"
